Session Details

[S26]Research and development on viral vectors and non-viral vectors to realize gene-vector-mediated disease therapy

Thu. Mar 27, 2025 5:00 PM - 6:30 PM JST
Thu. Mar 27, 2025 8:00 AM - 9:30 AM UTC
Room 20 (FUKUOKA SUNPALACE: Palace RoomB [2F])
Organizer: Yuma Yamada (Fac. Pharm. Sci., Hokkaido Univ.), Sakurai Fuminori (Grad. Sch. Pharm. Sci., Osaka Univ.)

趣旨説明:山田 勇磨(北大院薬)

[S26-1]Delivery of CRISPR/Cas based on lipid nanoparticles

○Yusuke Sato1 (1. Fac. of Pharm. Sci., Hokkaido Univ.)

[S26-2]Roles of extracellular vesicles in antitumor effects of oncolytic viruses

○Fuminori Sakurai1,2 (1. Faculty of Pharm., Kindai Univ., 2. Grad.Sch.Pharm.Sci., Osaka Univ.)

[S26-3]Hypertonic intranasal adenovirus vector vaccines gain nasal epithelia access to exert strong immunogenicity

○Toshiro Hirai1,2,3,4, Yasuo Yoshioka1,2,3,4,5 (1. OTRI, Osaka Univ., 2. RIMD, Osaka Univ., 3. Grad. Sch. Pharm. Sci., Osaka Univ., 4. CAMaD, Osaka Univ., 5. BIKEN)

[S26-4]Cytoplasmic genome regulation; development of organellar genome editing and their application

○Shin-ichi Arimura1 (1. Grad Sch Agr Life Sci, Univ Tokyo)

[S26-5]Development trends and research to ensure the safety of genome editing therapy

○Takao Inoue1 (1. NIHS)